Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator. 1988

M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
St. Vincent's Hospital, Darlinghurst, NSW, Australia.

In a double-blind randomized trial involving five Sydney hospitals and the city ambulance paramedical service, 145 patients with a first evolving myocardial infarction and with onset of pain less than 2.5 (mean 1.9 +/- 0.5 [SD]) hr previously were allocated to intravenous infusion of 100 mg recombinant tissue-type plasminogen activator (rt-PA) or placebo over 3 hr. The groups at entry were similar. At assessment 21 days later, left ventricular ejection fraction measured both by contrast and radionuclide ventriculography was higher in the rt-PA compared with the placebo group (61 +/- 13%, n = 64, vs 54 +/- 14%, n = 62, contrast, 2p = .006; 52 +/- 13%, n = 66, vs 48 +/- 13%, n = 62 isotope, 2p = .08). This indicates limitation of myocardial infarction by rt-PA.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
October 1990, Journal of the American College of Cardiology,
M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
August 1991, Zhonghua xin xue guan bing za zhi,
M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
September 1991, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
April 1988, Journal of the American College of Cardiology,
M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
September 1991, The Canadian journal of cardiology,
M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
September 1989, Irish medical journal,
M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
April 1989, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
May 2001, European journal of neurology,
M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
September 2015, The neurologist,
M O'Rourke, and D Baron, and A Keogh, and R Kelly, and G Nelson, and C Barnes, and J Raftos, and K Graham, and K Hillman, and H Newman
September 1989, The American journal of cardiology,
Copied contents to your clipboard!